# Pipeline Activity Log

> **Review:** Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection  
> **Date:** 2026-03-26 21:09  
> **Duration:** 1h 59m  
> **Total tokens:** 487,087 (input: 443,476 / output: 43,611)

> **Review URL:** https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003508.pub2/full  
> **Dataset split:** HIV_test  
> **Studies:** 10  

## Resource Usage by Agent

| Agent | Steps | Time | Tokens (in / out) |
|-------|-------|------|-------------------|
| Orchestrator | 11 | 1h 59m | 83,713 / 5,360 |
| Librarian | 4 | 10m 00s | 19,879 / 3,858 |
| Gatekeeper | 3 | 13m 07s | 38,535 / 4,878 |
| Miner | 3 | 9m 32s | 16,817 / 3,698 |
| Critic | 21 | 1h 09m | 284,532 / 25,817 |
| **Total** | **42** | **1h 59m** | **443,476 / 43,611** |

---

## Activity Timeline

### 1. Planning (Orchestrator)

*21:13:06 — 3m 35s — 3,313 tokens*

The orchestrator established a step-by-step workflow to execute a systematic review on cotrimoxazole prophylaxis for children with HIV. It defined a sequence of tasks that includes searching for candidate studies, screening them for eligibility, and extracting data from the selected trials. This plan coordinates the necessary steps to synthesize the evidence and generate a final review report.

---

### 2. Orchestrator → Librarian

*21:24:45 — 11m 38s — 30,097 tokens*

The orchestrator initiated the literature search to identify candidate studies for the systematic review on Cotrimoxazole prophylaxis in children with HIV. It executed a search task to locate eligible randomized and quasi-randomized trials according to the review's specific inclusion criteria. The search completed successfully, and the list of identified candidate studies was retrieved for the next stage of the pipeline.

> **Librarian — Step 1:** The librarian agent retrieved the systematic review protocol to establish the study objectives and eligibility criteria before formulating a search strategy. This document defined the focus on assessing the effects of Cotrimoxazole prophylaxis in children with HIV infection or infants of HIV-infected mothers. By confirming these parameters, the agent ensured the subsequent literature search would align with the defined guidelines for eligible randomised trials.
> **Librarian — Step 2:** The agent searched the literature database to identify randomized trials comparing cotrimoxazole prophylaxis against placebo or no treatment in children with HIV. It successfully located ten candidate studies that satisfied the review protocol's specific inclusion criteria regarding study design and participant age. The agent then retrieved the titles and abstracts for these studies to facilitate the subsequent evaluation process.
> **Librarian — Step 3:** The librarian agent initiated a literature search to identify candidate studies relevant to the systematic review objectives. It executed a search query targeting randomized controlled trials on cotrimoxazole prophylaxis in children with HIV. This process yielded ten candidate studies that are now ready for eligibility screening.
> **Librarian — Step 4 (result):** The librarian agent searched the literature database to identify randomized trials evaluating cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection. It identified ten candidate studies and added notes flagging their relevance, specifically noting whether the participants were children or adults. This step produced a finalized list of search results with preliminary assessments to guide the next stages of the systematic review.

---

### 3. Orchestrator → Gatekeeper

*21:39:10 — 14m 25s — 50,515 tokens*

The system reviewed the candidate list and identified ten potential studies for the review on cotrimoxazole prophylaxis in children with HIV. These studies were then forwarded to the eligibility screening phase to assess their alignment with the inclusion criteria. The screening process for these ten studies has now been completed.

> **Gatekeeper — Step 1:** The gatekeeper agent screened ten candidate studies to determine their eligibility for a systematic review on cotrimoxazole prophylaxis in children with HIV. Each trial was assessed against specific criteria requiring randomised comparisons of the treatment versus placebo or no treatment in children under fifteen years of age. The agent analyzed study details to assign an inclusion or exclusion status to each candidate based on the review protocol.
> **Gatekeeper — Step 2:** The gatekeeper agent screened ten candidate studies to determine eligibility based on the review's criteria for randomised trials in children with HIV. It systematically assessed each study's design and population, resulting in the inclusion of one trial that met all requirements and the exclusion of nine others. The excluded studies primarily failed due to adult populations, observational designs, or missing intervention comparisons.
> **Gatekeeper — Step 3 (result):** The screening agent evaluated ten candidate studies against the inclusion criteria for a systematic review on cotrimoxazole prophylaxis in children with HIV. Nine studies were excluded due to incorrect populations or study designs, while one randomised trial met all requirements. Consequently, the CHAP trial was selected to proceed to evidence extraction.

---

### 4. Orchestrator → Miner

*21:50:15 — 11m 04s — 28,436 tokens*

The orchestrator processed the screening results to identify the specific studies eligible for evidence extraction. It confirmed that one study met the inclusion criteria for the review investigating cotrimoxazole prophylaxis in children with HIV. The agent then executed the extraction task to compile structured data on the study population, interventions, and clinical outcomes.

> **Miner — Step 1:** The system extracted structured evidence from the single included study to support the systematic review. It analyzed a randomized trial on cotrimoxazole prophylaxis in HIV-infected children, capturing key data on mortality and adverse events. This process generated a detailed record of the study's primary findings, such as hazard ratios, for further analysis.
> **Miner — Step 2:** The agent extracted structured clinical evidence from the included trial regarding cotrimoxazole prophylaxis in HIV-infected children. It organized study details into standard categories, including population demographics, intervention specifics, and primary outcomes such as mortality and adverse events. Statistical measures like hazard ratios and confidence intervals were also captured, creating a complete data record for the systematic review.
> **Miner — Step 3 (result):** The agent extracted structured evidence from the CHAP trial to support the systematic review on cotrimoxazole prophylaxis in HIV-infected children. It organized critical data points including the patient population, intervention details, and statistical outcomes such as mortality rates and safety events. This final output delivers a comprehensive summary of the study's findings ready for evidence synthesis.

---

### 5. Planning (Orchestrator)

*21:52:06 — 1m 51s — 4,407 tokens*

The coordinating agent reviewed the research protocol to confirm the objectives and selection criteria for the systematic review on Cotrimoxazole prophylaxis in children with HIV. It structured the workflow to handle literature retrieval, study screening, and evidence synthesis while confirming the designated output location for the final data. This planning activity ensures that the automated pipeline proceeds with a clear understanding of the research requirements.

---

### 6. Orchestrator → Critic

*22:33:07 — 41m 01s — 194,947 tokens*

The orchestrator initiated the quality assessment and narrative synthesis for the cotrimoxazole prophylaxis review, focusing on mortality and safety outcomes in children with HIV. This process aimed to consolidate the extracted evidence into a coherent analysis of study quality and intervention effectiveness. However, the task was not fully completed because the operation exceeded the allowed time limit during execution.

> **Critic — Step 1:** The critic agent attempted to conduct a quality assessment and narrative synthesis of the evidence regarding cotrimoxazole prophylaxis. While it successfully retrieved the study details from the CHAP trial, an issue occurred when trying to organize the data for analysis. Consequently, the agent could not finish the quality assessment or generate the evidence synthesis at this time.
> **Critic — Step 2:** The agent verified the quality and structure of the evidence extracted from the previous search step. It successfully processed data from one included study regarding cotrimoxazole prophylaxis in HIV-infected children in Zambia. This validation confirmed that the study citation, participant characteristics, and primary mortality outcomes were correctly organized for synthesis.
> **Critic — Step 3:** The critic agent evaluated the quality of evidence extracted from a clinical trial investigating cotrimoxazole prophylaxis in children with HIV. It systematically analyzed the study data to assess methodological rigor and reported outcomes, generating a comprehensive quality report. This assessment confirmed the trial's randomized design and summarized key findings regarding mortality benefits and adverse events.
> **Critic — Step 4:** The agent synthesized the extracted data into a cohesive evidence summary aligned with the review's question about cotrimoxazole effects in children with HIV infection. It generated a structured report detailing the trial design, population demographics, and key outcomes including mortality and adverse events. This output provides the necessary consolidated findings to support the subsequent quality assessment and interpretation phases of the review.
> **Critic — Step 5:** The agent intended to finalize the quality assessment and narrative synthesis for the included CHAP trial regarding cotrimoxazole prophylaxis in children. It assessed the study as high quality with low risk of bias and summarized findings on mortality and safety outcomes. However, the process was interrupted by a technical error, preventing the final consolidated report from being successfully completed.
> **Critic — Step 6:** The critic agent evaluated the included CHAP trial, assigning it a high-quality rating while documenting specific strengths and limitations regarding its study design. It generated a narrative synthesis summarizing key findings on mortality reduction, opportunistic infection prevention, and safety outcomes derived from the evidence. This assessment and synthesis were validated successfully and are now ready for the final review output.
> **Critic — Step 7:** The agent synthesised the extracted evidence to evaluate the quality of included studies and consolidate clinical findings regarding cotrimoxazole prophylaxis. It determined that the single high-quality trial demonstrated a significant mortality benefit with a favourable safety profile across diverse patient subgroups. Consequently, the overall evidence strength was rated as moderate due to reliance on a single study, despite the trial's low risk of bias.
> **Critic — Step 8:** The critic agent evaluated the methodological quality of the included CHAP trial, rating it as high quality with a low risk of bias. It synthesized the clinical findings to confirm that cotrimoxazole prophylaxis significantly reduces mortality in HIV-infected children, while noting limitations such as single-site recruitment and early trial termination. The agent finalized a comprehensive report categorizing the overall evidence strength as moderate due to reliance on a single study.
> **Critic — Step 9 (result):** The agent synthesized the extracted evidence and assessed the quality of the included study to produce the final review output. It evaluated the CHAP trial's methodology and determined the study was high quality with a low risk of bias. This assessment generated a final report confirming that cotrimoxazole prophylaxis significantly reduces mortality in HIV-infected children, providing moderate-strength evidence consistent with WHO guidelines.

> ⚠️ **Error:** Code execution exceeded the maximum execution time of 1000 seconds

---

### 7. Orchestrator → Critic

*22:58:27 — 25m 19s — 113,622 tokens*

The orchestrator agent directed a comprehensive synthesis of evidence regarding cotrimoxazole prophylaxis for children with HIV infection. This task aimed to assess study quality and summarize key findings on mortality and morbidity outcomes. Unfortunately, the process did not complete successfully because it exceeded the system's maximum execution time limit.

> **Critic — Step 1:** The critic agent intended to evaluate the quality of the evidence extracted from the CHAP trial and synthesize the findings. It attempted to process this data to perform the assessment, but the action failed because the system could not correctly read the provided information. As a result, the quality appraisal and evidence synthesis were not completed during this step.
> **Critic — Step 2:** The agent identified a formatting issue where introductory text appeared before the main study evidence. It inspected the start and end of the response to understand how the data was organized. This review confirmed that the trial results were mixed with descriptive text, requiring separation to ensure accurate data synthesis.
> **Critic — Step 3:** The critic agent processed the evidence response to isolate structured data required for quality assessment. It successfully parsed the information for a single randomized controlled trial evaluating cotrimoxazole prophylaxis in HIV-infected Zambian children. This extraction confirmed the availability of key study details, including participant population, intervention specifics, and mortality outcome data.
> **Critic — Step 4:** The critic agent attempted to assess the quality of the extracted evidence against the review's objectives. However, the assessment could not be completed because the evaluation process did not accept the provided review goals. Consequently, the quality of the evidence remains unassessed in this step.
> **Critic — Step 5:** The system conducted a quality assessment on the extracted evidence from the included studies. It specifically reviewed a randomized trial involving Cotrimoxazole prophylaxis for HIV-infected children in Zambia. The process analyzed study design and outcome data to determine the reliability of the evidence.
> **Critic — Step 6:** The agent synthesized the extracted evidence to address the research question on cotrimoxazole prophylaxis in children with HIV. It organized key trial information, such as participant demographics and mortality statistics, into a comprehensive evidence summary. This output provides the consolidated data necessary for the agent to assess the quality of the included studies.
> **Critic — Step 7:** The agent evaluated the methodological quality of the included trial and synthesized the clinical evidence regarding cotrimoxazole prophylaxis. It assigned a high quality rating with a low risk of bias, documenting specific design strengths alongside limitations such as early trial termination. The activity produced a structured quality assessment and a narrative summary of mortality and safety outcomes for the systematic review.
> **Critic — Step 8:** The critic agent completed the evidence synthesis and quality assessment step for the cotrimoxazole prophylaxis systematic review. It analyzed the single included trial, identifying significant mortality benefits and a high-quality design despite limitations from early termination. The agent finalized the review output by generating a detailed report with a moderate overall evidence strength rating.
> **Critic — Step 9 (result):** The critic agent synthesized the available study data to evaluate the quality and effectiveness of cotrimoxazole prophylaxis for children with HIV infection. It assessed the single included trial, confirming a high-quality design while noting limitations like early termination that affected overall evidence strength. The agent produced a comprehensive final report concluding that the treatment significantly reduces mortality with a moderate level of evidence strength.

> ⚠️ **Error:** Code execution exceeded the maximum execution time of 1000 seconds

---

### 8. Orchestrator → Critic

*23:05:31 — 7m 04s — 32,289 tokens*

The orchestrator verified that all necessary evidence and study lists from previous stages were available. It then directed the critic agent to evaluate study quality and synthesize findings concerning cotrimoxazole treatment for children with HIV. This process completed successfully, confirming the assessment task was executed as intended.

> **Critic — Step 1:** The agent evaluated the methodological quality of the extracted evidence from the CHAP clinical trial. It analyzed study details such as the trial design, population, and reported mortality outcomes to determine the reliability of the findings. This process generated a quality rating for the study to support the overall evidence synthesis.
> **Critic — Step 2:** The critic agent consolidated the extracted study data to evaluate the effects of cotrimoxazole prophylaxis on mortality and illness in HIV-infected children. It combined detailed trial findings, including mortality hazard ratios and adverse event rates, to generate a structured evidence synthesis. The resulting output aligns with the review objective and summarizes the key clinical outcomes from the included research.
> **Critic — Step 3 (result):** The critic agent evaluated the methodological quality of the identified evidence regarding cotrimoxazole prophylaxis for HIV-infected children. It rated the single included randomized controlled trial as high quality with a low risk of bias, documenting specific strengths and limitations such as early trial termination. Finally, the agent synthesized the findings into a narrative summary confirming significant mortality benefits and an acceptable safety profile, resulting in a moderate overall evidence strength rating for the final output.

---

### 9. Planning (Orchestrator)

*23:07:19 — 1m 48s — 5,228 tokens*

The pipeline manager assessed the current progress of the systematic review on cotrimoxazole prophylaxis for children with HIV. Noting that ten candidate studies were retrieved and one met the inclusion criteria, it outlined the remaining workflow required to finalize the review. The agent planned to proceed with evidence extraction, data synthesis, and the generation of the final report.

---

### 10. Orchestrator (python_interpreter)

*23:08:48 — 1m 29s — 11,961 tokens*

The orchestrator agent completed the systematic review workflow by compiling a final report on cotrimoxazole prophylaxis for children with HIV infection. It integrated the screening and synthesis results into this document and stored the underlying evidence data for future reference. Both the report generation and data storage actions executed successfully.

---

### 11. Final Output (Orchestrator)

*23:09:04 — 15s — 12,272 tokens*

The orchestrator agent concluded the automated pipeline by generating the final systematic review report. It compiled the search findings and eligibility assessments into a structured document that outlines the review objective and details the inclusion of one trial alongside rationales for excluding other candidates. This completed output provides a comprehensive summary of the evidence regarding cotrimoxazole prophylaxis for children with HIV infection.

---
